RGEN News and Press, Repligen Corporation From 01/20/22

As a sector, healthcare can be hit or miss for investors. Many companies end up going bust, but some go on to multibagger returns that could help set you up for life. Repligen (NASDAQ: RGEN) and ResMed (NYSE: RMD) are two stocks which could fit that bill with their p...

WALTHAM, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the 40th Annual J.P. Morgan Healthcare conference being held January 10-13.&#x...

Interesting insights can be made while looking at broader market performance comparisons. As major trends are slow to change, these insights can be used to find returns into early 2022 and beyond. While some strong points can be made using the data, factors for each individual hol...

This is the second part of my update on the holdings in my portfolios. A strong group of long-horizon companies and turnaround plays, best suited for risk-averse investors, especially at current valuations. In the articles, I deep dive my thesis on most of these names, so feel fre...

Although the Healthcare sector is having a positive year in absolute terms, that isn't the case in relative terms. Biotech stocks are having a difficult year, in spite of many of those trading at dirt-cheap valuations that don't even reflect the cash they have in-hand. It's very l...

My new portfolio has already seen most companies release earnings, and results look promising. Therefore, I will cover the first thirteen companies in this article, and then the last twelve after all reports have been filed. I will be quite brief with my summaries, but I will cove...

WALTHAM, Mass., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today released its inaugural sustainability report, available on the Company’s website . Repligen’s 2020 Sustainability Report provides an overview of the Company’s environmental, ...

Image source: The Motley Fool. Repligen Corp (NASDAQ: RGEN) Q3 2021 Earnings Call Oct 28, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Repligen Corp (RGEN) Q3 2021 Earnings Call Transcript

Repligen Corporation (RGEN) Q3 2021 Earnings Conference Call October 28, 2021 08:30 AM ET Company Participants Sondra Newman - Head of Investor Relations Anthony Hunt - President and Chief Executive Officer Jon Snodgres - Chief Financial Officer Conference Call Participants Daniel Arias - Sti...

Repligen shares rise (RGEN +6.2%) after the company posted third-quarter profit and revenue that beat Wall Street estimates and raised its FY forecast. The company raised its profit per share forecast for the year to a range of $2.86-$2.91, up from a prior guidance of $2.71-$2.78. Total reven...